Company news
Adhera Therapeutics Inc. news in 2012
Adhera Therapeutics Inc.'s news releases, calls and decks from 2012, newest first.
Marina Biotech, Inc. Announces Year-to-Date 2012 Financial Results and Highlights Corporate Accomplishments
December 6, 2012
Marina Biotech Announces that Licensee ProNAi Therapeutics Reported Phase 1 Study Results using SMARTICLES® Nucleic Acid Delivery Technology
December 5, 2012
Marina Biotech Receives Key Patent Issuance from the USPTO for its Unlocked Nucleobase Analog (UNA) Chemistry - Patent broadly covers RNA-based oligonucleotide therapeutics containing a UNA
December 4, 2012
Marina Biotech Announces Worldwide Non-Exclusive Licensing Agreement
November 29, 2012
Marina Biotech, Inc. Announces Full Year 2011 Financial Results
October 11, 2012
Marina Biotech Provides Update on Company Operations
August 22, 2012
Marina Biotech Announces Worldwide Non-Exclusive Licensing Agreement for Nucleic Acid Chemistry
August 3, 2012
Marina Biotech Ceases Most Day-to-Day Operations
June 1, 2012
Marina Biotech and Girindus Group Announce Strategic Alliance
May 21, 2012
Marina Biotech Receives Three Notices of Allowances from the USPTO and an Intent to Grant Notice from the European Patent Office
May 10, 2012
Marina Biotech Announces Worldwide Exclusive Licensing Agreement with Monsanto
May 8, 2012
Marina Biotech Regains Intellectual Property Rights to its tkRNAi™ Technology for Agriculture and Veterinary Uses
April 19, 2012
Marina Biotech Completes Dosing of Second Cohort in the Phase 1b START-FAP Clinical Trial of CEQ508
April 3, 2012
Marina Biotech, Inc. to Raise $1.2 Million in Registered Direct Offering
March 18, 2012
Marina Biotech and ProNAi Therapeutics Announce License Agreement for the Development of DNAi-based Therapeutics
March 14, 2012
Marina Biotech Presents Advances in Oral Delivery of Nucleic Acids at AsiaTIDES Conference in Tokyo
February 29, 2012
Marina Biotech Receives Notice of Allowance for U.S. Patent Related to Its Lipid Based Nucleic Acid Drug Delivery Platform
February 22, 2012
Marina Biotech Announces Closure of Cambridge Site and Consolidation of R&D Operations in Bothell, WA
February 14, 2012
Marina Biotech Announces Closing of $1.5 MM Bridge Loan
February 10, 2012
Marina Biotech Begins Trading on the OTCQX Tier of OTC Market
February 1, 2012